Founded in 2010, Nuvera focuses exclusively on the rare disease and specialty therapeutics markets. The firm helps pharma and biotech firms design and enable seamless and streamlined treatment experiences.
The consulting firm's team of more than 20 employees has supported 7 of the top 10 pharma companies, as well as numerous startups and mid-sized firms.
Ashfield Engage's acquisition of Nuvera will enhance the company's patient solutions practice. The addition of Nuvera will create a strategic offering that stretches across the pharma product lifecycle, including late-phase clinical trial experience, implementation, and post-commercialization satisfaction benchmarking and service optimization.
To continue reading, become an ALM digital reader
Benefits include:
- Authoritative and broad coverage of the business of consulting
- Industry-leading awards programs like Best Firms to Work For, Global Leades and Rising Stars
- An informative newsletter that goes into the trends shaping the industry
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
